French clinical-stage biotech Sensorion (Euronext: ALSEN) has raised 60 million euros ($65 million) in a reserved equity ...

South Korean drugmaker Hanmi (KRX: 128940) has signed an exclusive distribution agreement with Mexico’s Laboratorios Sanfer ...

San Francisco-based Cellares, a company that calls itself the first integrated development and manufacturing organization ...

US biotech Gilead Sciences today announced that its Trodelvy (sacituzumab govitecan-hziy) has now been added to the National ...

The US Food and Drug Administration (FDA) yesterday approved daratumumab and hyaluronidase-fihj – trade name Darzalex Faspro ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for litifilimab (BIIB059) for the ...

Israeli drugmaker Teva Pharmaceutical Industries has presented its annual results for 2025, heralding three consecutive years ...

The US Centers for Medicare & Medicaid Services (CMS) has announced the selection of 15 high-cost prescription medicines ...

Swiss contract development and manufacturing group Lonza today reported sales of 6.5 billion francs ($5.14 billion) in full ...

The US Food and Drug Administration (FDA) has placed a clinical hold on Regenxbio’s investigational gene therapy, RGX-111, ...

Private gene editing company Seamless Therapeutics has announced that it has entered into a strategic global research ...